- ImmuCell Corporation (NASDAQ:ICCC) announced preliminary sales of $7.8 million in the fourth quarter, up 52% from the fourth quarter of 2023.
- Co sees fiscal 2024 sales of $26.5 million, also up 52% from 2023.
- The company believes the current backlog reflects strong demand as distributors work to replenish their buffer stocks and as end users place orders ahead of the peak calving season in the first quarter.
-
Source: Press release